NERV
Price:
$3.74
Market Cap:
$26.16M
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, ...[Read more]
Industry
Biotechnology
IPO Date
2014-07-01
Stock Exchange
NASDAQ
Ticker
NERV
According to Minerva Neurosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -0.00%. This represents a change of -100.00% compared to the average of 9.91% of the last 4 quarters.
The mean historical ROE of Minerva Neurosciences, Inc. over the last ten years is -77.39%. The current -0.00% ROE has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), NERV's ROE was at its highest in in the March 2022 quarter at 1.33%. The ROE was at its lowest in in the December 2021 quarter at -267.15%.
Average
-77.39%
Median
-26.62%
Minimum
-625.73%
Maximum
160.35%
Discovering the peaks and valleys of Minerva Neurosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 367.49%
Maximum Annual ROE = 160.35%
Minimum Annual Increase = -17077.11%
Minimum Annual ROE = -625.73%
| Year | ROE | Change |
|---|---|---|
| 2024 | -0.01% | -100.01% |
| 2023 | 105.44% | -34.25% |
| 2022 | 160.35% | -125.63% |
| 2021 | -625.73% | -17077.11% |
| 2020 | 3.69% | -101.42% |
| 2019 | -259.84% | 367.49% |
| 2018 | -55.58% | 132.04% |
| 2017 | -23.95% | -18.22% |
| 2016 | -29.29% | -40.16% |
| 2015 | -48.96% | -55.69% |
The current ROE of Minerva Neurosciences, Inc. (NERV) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
88.59%
5-year avg
-71.25%
10-year avg
-77.39%
Minerva Neurosciences, Inc.’s ROE is greater than Klotho Neurosciences, Inc. (-201.59%), greater than Sonnet BioTherapeutics Holdings, Inc. (-4648.06%), less than NeuroSense Therapeutics Ltd. (2.72%), greater than Exicure, Inc. (-110.40%), greater than NeurAxis, Inc. (-340.23%), greater than CollPlant Biotechnologies Ltd. (-102.03%), greater than TAO Synergies Inc. (-256.58%), greater than Rallybio Corporation (-71.66%), greater than Cadrenal Therapeutics, Inc. Common Stock (-279.52%), greater than Enlivex Therapeutics Ltd. (-62.91%),
| Company | ROE | Market cap |
|---|---|---|
| -201.59% | $25.82M | |
| -4648.06% | $8.43M | |
| 2.72% | $29.60M | |
| -110.40% | $42.96M | |
| -340.23% | $28.86M | |
| -102.03% | $26.70M | |
| -256.58% | $23.26M | |
| -71.66% | $28.16M | |
| -279.52% | $23.04M | |
| -62.91% | $28.19M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Minerva Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Minerva Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Minerva Neurosciences, Inc.'s ROE?
How is the ROE calculated for Minerva Neurosciences, Inc. (NERV)?
What is the highest ROE for Minerva Neurosciences, Inc. (NERV)?
What is the 3-year average ROE for Minerva Neurosciences, Inc. (NERV)?
What is the 5-year average ROE for Minerva Neurosciences, Inc. (NERV)?
How does the current ROE for Minerva Neurosciences, Inc. (NERV) compare to its historical average?